Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.898 | 3.46e-16 | 2.24e-04 | 1.96e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
KDM4B | 23030 | 5 | -3.892 | 3.216 | 5 | Yes | - |
LUC7L3 | 51747 | 33 | -3.523 | 3.449 | 18 | Yes | - |
PHB | 5245 | 15 | -2.743 | 3.004 | 127 | Yes | Yes |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
SRSF3 | 6428 | 73 | -2.992 | 3.538 | 54 | Yes | - |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
MVP | 9961 | 16 | -2.846 | 3.193 | 20 | Yes | Yes |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
[ ESR1 ] | 2099 | 1 | 2.117 | 2.898 | 608 | - | - |
DDIT3 | 1649 | 60 | -2.825 | 3.504 | 343 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
ESR1 | 2099 | LUC7L3 | 51747 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
ESR1 | 2099 | MVP | 9961 | pp | -- | int.I2D: BCI, BioGrid, HPRD; int.HPRD: in vitro, in vivo |
ESR1 | 2099 | PHB | 5245 | pp | -- | int.I2D: BioGrid |
ESR1 | 2099 | HNRNPU | 3192 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
ESR1 | 2099 | SRSF3 | 6428 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
ESR1 | 2099 | KDM4B | 23030 | pp | -- | int.I2D: BioGrid_Mouse |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0005654 | nucleoplasm | 1.29e-06 | 1.86e-02 | 3.222 | 7 | 64 | 1082 |
GO:0044212 | transcription regulatory region DNA binding | 3.53e-06 | 5.09e-02 | 5.102 | 4 | 17 | 168 |
GO:0006355 | regulation of transcription, DNA-templated | 1.77e-05 | 2.56e-01 | 3.118 | 6 | 43 | 997 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 3.36e-05 | 4.85e-01 | 7.794 | 2 | 2 | 13 |
GO:0005634 | nucleus | 2.24e-04 | 1.00e+00 | 1.510 | 9 | 159 | 4559 |
GO:0008380 | RNA splicing | 4.31e-04 | 1.00e+00 | 4.246 | 3 | 22 | 228 |
GO:0008134 | transcription factor binding | 5.13e-04 | 1.00e+00 | 4.160 | 3 | 18 | 242 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0023057 | negative regulation of signaling | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0072376 | protein activation cascade | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0038052 | estrogen-activated sequence-specific DNA binding RNA polymerase II transcription factor activity | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 7.25e-04 | 1.00e+00 | 5.612 | 2 | 6 | 59 |
GO:0010467 | gene expression | 7.70e-04 | 1.00e+00 | 3.108 | 4 | 45 | 669 |
GO:0060242 | contact inhibition | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0001547 | antral ovarian follicle growth | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0001649 | osteoblast differentiation | 1.75e-03 | 1.00e+00 | 4.971 | 2 | 5 | 92 |
GO:0060745 | mammary gland branching involved in pregnancy | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 |
GO:0060523 | prostate epithelial cord elongation | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 |
GO:0005515 | protein binding | 2.41e-03 | 1.00e+00 | 1.108 | 9 | 198 | 6024 |
GO:0030529 | ribonucleoprotein complex | 2.58e-03 | 1.00e+00 | 4.687 | 2 | 5 | 112 |
GO:0034056 | estrogen response element binding | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0038127 | ERBB signaling pathway | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0030284 | estrogen receptor activity | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0001714 | endodermal cell fate specification | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 2 | 5 |
GO:0048386 | positive regulation of retinoic acid receptor signaling pathway | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 2 | 6 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 3 | 6 |
GO:0044822 | poly(A) RNA binding | 4.19e-03 | 1.00e+00 | 2.450 | 4 | 50 | 1056 |
GO:0042981 | regulation of apoptotic process | 4.58e-03 | 1.00e+00 | 4.265 | 2 | 4 | 150 |
GO:0006974 | cellular response to DNA damage stimulus | 4.64e-03 | 1.00e+00 | 4.256 | 2 | 7 | 151 |
GO:0060687 | regulation of branching involved in prostate gland morphogenesis | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 7 |
GO:0071354 | cellular response to interleukin-6 | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 7 |
GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 7 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 7 |
GO:0000398 | mRNA splicing, via spliceosome | 5.45e-03 | 1.00e+00 | 4.137 | 2 | 15 | 164 |
GO:0002064 | epithelial cell development | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 8 |
GO:0001955 | blood vessel maturation | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 8 |
GO:0010863 | positive regulation of phospholipase C activity | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 8 |
GO:0016607 | nuclear speck | 5.97e-03 | 1.00e+00 | 4.068 | 2 | 12 | 172 |
GO:0030235 | nitric-oxide synthase regulator activity | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 9 |
GO:0031953 | negative regulation of protein autophosphorylation | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 9 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 9 |
GO:0003714 | transcription corepressor activity | 6.39e-03 | 1.00e+00 | 4.018 | 2 | 11 | 178 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 6.81e-03 | 1.00e+00 | 3.971 | 2 | 22 | 184 |
GO:0035413 | positive regulation of catenin import into nucleus | 6.91e-03 | 1.00e+00 | 7.172 | 1 | 2 | 10 |
GO:0003677 | DNA binding | 7.02e-03 | 1.00e+00 | 2.244 | 4 | 49 | 1218 |
GO:0060068 | vagina development | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 1 | 11 |
GO:0060065 | uterus development | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 3 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 4 | 11 |
GO:0008209 | androgen metabolic process | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 12 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 3 | 13 |
GO:0071480 | cellular response to gamma radiation | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 13 |
GO:0051213 | dioxygenase activity | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 13 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 6 | 14 |
GO:0005685 | U1 snRNP | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 1 | 14 |
GO:0005496 | steroid binding | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 15 |
GO:0001824 | blastocyst development | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 2 | 15 |
GO:0060749 | mammary gland alveolus development | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 2 | 15 |
GO:0006376 | mRNA splice site selection | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 15 |
GO:0051000 | positive regulation of nitric-oxide synthase activity | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 15 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.05e-02 | 1.00e+00 | 2.630 | 3 | 39 | 699 |
GO:0043274 | phospholipase binding | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 16 |
GO:0035327 | transcriptionally active chromatin | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 2 | 17 |
GO:0071392 | cellular response to estradiol stimulus | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 2 | 18 |
GO:0030520 | intracellular estrogen receptor signaling pathway | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 4 | 18 |
GO:0032757 | positive regulation of interleukin-8 production | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 1 | 20 |
GO:0016575 | histone deacetylation | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 3 | 21 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.47e-02 | 1.00e+00 | 2.455 | 3 | 41 | 789 |
GO:0019899 | enzyme binding | 1.49e-02 | 1.00e+00 | 3.380 | 2 | 9 | 277 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 2 | 22 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 1 | 23 |
GO:0035329 | hippo signaling | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 5 | 26 |
GO:0001046 | core promoter sequence-specific DNA binding | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 26 |
GO:0071897 | DNA biosynthetic process | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 1 | 28 |
GO:0008283 | cell proliferation | 2.06e-02 | 1.00e+00 | 3.137 | 2 | 14 | 328 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 2 | 30 |
GO:0042594 | response to starvation | 2.13e-02 | 1.00e+00 | 5.540 | 1 | 4 | 31 |
GO:0016020 | membrane | 2.16e-02 | 1.00e+00 | 1.779 | 4 | 46 | 1681 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 2 | 32 |
GO:0003723 | RNA binding | 2.22e-02 | 1.00e+00 | 3.076 | 2 | 18 | 342 |
GO:0043565 | sequence-specific DNA binding | 2.27e-02 | 1.00e+00 | 3.060 | 2 | 11 | 346 |
GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 1 | 34 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 35 |
GO:0005737 | cytoplasm | 2.44e-02 | 1.00e+00 | 1.200 | 6 | 124 | 3767 |
GO:0005925 | focal adhesion | 2.53e-02 | 1.00e+00 | 2.978 | 2 | 9 | 366 |
GO:0035019 | somatic stem cell maintenance | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 6 | 40 |
GO:0031124 | mRNA 3'-end processing | 2.88e-02 | 1.00e+00 | 5.102 | 1 | 2 | 42 |
GO:0048146 | positive regulation of fibroblast proliferation | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 1 | 44 |
GO:0003707 | steroid hormone receptor activity | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 1 | 45 |
GO:0006369 | termination of RNA polymerase II transcription | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 2 | 45 |
GO:0043525 | positive regulation of neuron apoptotic process | 3.14e-02 | 1.00e+00 | 4.971 | 1 | 4 | 46 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.16e-02 | 1.00e+00 | 2.804 | 2 | 24 | 413 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.25e-02 | 1.00e+00 | 2.783 | 2 | 30 | 419 |
GO:0006986 | response to unfolded protein | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 4 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 3.48e-02 | 1.00e+00 | 4.822 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 3.48e-02 | 1.00e+00 | 4.822 | 1 | 1 | 51 |
GO:0043401 | steroid hormone mediated signaling pathway | 3.48e-02 | 1.00e+00 | 4.822 | 1 | 1 | 51 |
GO:0051028 | mRNA transport | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 4 | 52 |
GO:0009611 | response to wounding | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 5 | 52 |
GO:0043627 | response to estrogen | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 5 | 56 |
GO:0005643 | nuclear pore | 3.88e-02 | 1.00e+00 | 4.661 | 1 | 11 | 57 |
GO:0006396 | RNA processing | 4.02e-02 | 1.00e+00 | 4.612 | 1 | 5 | 59 |
GO:0008013 | beta-catenin binding | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 9 | 60 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.14e-02 | 1.00e+00 | 2.593 | 2 | 24 | 478 |
GO:0006406 | mRNA export from nucleus | 4.15e-02 | 1.00e+00 | 4.563 | 1 | 4 | 61 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 4.15e-02 | 1.00e+00 | 4.563 | 1 | 2 | 61 |
GO:0019903 | protein phosphatase binding | 4.22e-02 | 1.00e+00 | 4.540 | 1 | 2 | 62 |
GO:0006338 | chromatin remodeling | 4.48e-02 | 1.00e+00 | 4.450 | 1 | 3 | 66 |
GO:0010468 | regulation of gene expression | 4.62e-02 | 1.00e+00 | 4.407 | 1 | 2 | 68 |
GO:0032355 | response to estradiol | 4.82e-02 | 1.00e+00 | 4.344 | 1 | 3 | 71 |
GO:0042826 | histone deacetylase binding | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 4 | 72 |
GO:0003729 | mRNA binding | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 4 | 72 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 5.02e-02 | 1.00e+00 | 4.285 | 1 | 4 | 74 |
GO:0008584 | male gonad development | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 3 | 75 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 1 | 75 |
GO:0010629 | negative regulation of gene expression | 5.21e-02 | 1.00e+00 | 4.227 | 1 | 4 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 7 | 78 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 5.35e-02 | 1.00e+00 | 4.190 | 1 | 2 | 79 |
GO:0009653 | anatomical structure morphogenesis | 5.61e-02 | 1.00e+00 | 4.119 | 1 | 2 | 83 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 5.81e-02 | 1.00e+00 | 4.068 | 1 | 8 | 86 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 6.20e-02 | 1.00e+00 | 3.971 | 1 | 7 | 92 |
GO:0005770 | late endosome | 6.27e-02 | 1.00e+00 | 3.955 | 1 | 2 | 93 |
GO:0016568 | chromatin modification | 6.59e-02 | 1.00e+00 | 3.879 | 1 | 4 | 98 |
GO:0007204 | positive regulation of cytosolic calcium ion concentration | 6.85e-02 | 1.00e+00 | 3.822 | 1 | 2 | 102 |
GO:0030308 | negative regulation of cell growth | 7.37e-02 | 1.00e+00 | 3.713 | 1 | 6 | 110 |
GO:0007050 | cell cycle arrest | 8.27e-02 | 1.00e+00 | 3.540 | 1 | 5 | 124 |
GO:0016055 | Wnt signaling pathway | 9.17e-02 | 1.00e+00 | 3.386 | 1 | 4 | 138 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 9.74e-02 | 1.00e+00 | 3.294 | 1 | 6 | 147 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.09e-01 | 1.00e+00 | 3.128 | 1 | 12 | 165 |
GO:0005667 | transcription factor complex | 1.15e-01 | 1.00e+00 | 3.043 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 1.17e-01 | 1.00e+00 | 3.018 | 1 | 5 | 178 |
GO:0007165 | signal transduction | 1.27e-01 | 1.00e+00 | 1.669 | 2 | 13 | 907 |
GO:0008270 | zinc ion binding | 1.49e-01 | 1.00e+00 | 1.533 | 2 | 27 | 997 |
GO:0003713 | transcription coactivator activity | 1.53e-01 | 1.00e+00 | 2.605 | 1 | 24 | 237 |
GO:0000166 | nucleotide binding | 1.66e-01 | 1.00e+00 | 2.477 | 1 | 13 | 259 |
GO:0005743 | mitochondrial inner membrane | 1.76e-01 | 1.00e+00 | 2.380 | 1 | 6 | 277 |
GO:0005856 | cytoskeleton | 1.84e-01 | 1.00e+00 | 2.309 | 1 | 9 | 291 |
GO:0019901 | protein kinase binding | 1.99e-01 | 1.00e+00 | 2.186 | 1 | 18 | 317 |
GO:0003682 | chromatin binding | 2.05e-01 | 1.00e+00 | 2.141 | 1 | 19 | 327 |
GO:0030054 | cell junction | 2.10e-01 | 1.00e+00 | 2.102 | 1 | 5 | 336 |
GO:0015031 | protein transport | 2.13e-01 | 1.00e+00 | 2.081 | 1 | 11 | 341 |
GO:0008285 | negative regulation of cell proliferation | 2.20e-01 | 1.00e+00 | 2.031 | 1 | 10 | 353 |
GO:0046982 | protein heterodimerization activity | 2.34e-01 | 1.00e+00 | 1.924 | 1 | 8 | 380 |
GO:0005829 | cytosol | 2.43e-01 | 1.00e+00 | 0.794 | 3 | 86 | 2496 |
GO:0009986 | cell surface | 2.46e-01 | 1.00e+00 | 1.843 | 1 | 9 | 402 |
GO:0055114 | oxidation-reduction process | 2.56e-01 | 1.00e+00 | 1.780 | 1 | 10 | 420 |
GO:0006351 | transcription, DNA-templated | 2.65e-01 | 1.00e+00 | 0.996 | 2 | 57 | 1446 |
GO:0044267 | cellular protein metabolic process | 2.84e-01 | 1.00e+00 | 1.605 | 1 | 20 | 474 |
GO:0042802 | identical protein binding | 2.89e-01 | 1.00e+00 | 1.575 | 1 | 19 | 484 |
GO:0048471 | perinuclear region of cytoplasm | 2.98e-01 | 1.00e+00 | 1.523 | 1 | 8 | 502 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.32e-01 | 1.00e+00 | 1.339 | 1 | 37 | 570 |
GO:0005794 | Golgi apparatus | 3.51e-01 | 1.00e+00 | 1.241 | 1 | 9 | 610 |
GO:0005887 | integral component of plasma membrane | 4.70e-01 | 1.00e+00 | 0.700 | 1 | 10 | 888 |
GO:0005739 | mitochondrion | 5.12e-01 | 1.00e+00 | 0.531 | 1 | 23 | 998 |
GO:0070062 | extracellular vesicular exosome | 5.15e-01 | 1.00e+00 | 0.265 | 2 | 57 | 2400 |
GO:0005886 | plasma membrane | 5.58e-01 | 1.00e+00 | 0.160 | 2 | 49 | 2582 |
GO:0005524 | ATP binding | 6.11e-01 | 1.00e+00 | 0.152 | 1 | 31 | 1298 |
GO:0005730 | nucleolus | 7.01e-01 | 1.00e+00 | -0.186 | 1 | 66 | 1641 |
GO:0016021 | integral component of membrane | 7.72e-01 | 1.00e+00 | -0.459 | 1 | 17 | 1982 |